Omeros OMER
NASDAQ OMER
$18.47 -0.57 (-2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Omeros (OMER) Non Operating Interest Expenses (2010 - 2026)

Updated

Omeros' Non Operating Interest Expenses came in at $7.59 million for Q2 2026, compared with $15,000 a year earlier and up 28.7% from the prior quarter.

Analysis

Omeros (OMER) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Omeros reported Non Operating Interest Expenses of $8.85 million, down 18.8% year-over-year; for FY2025, it came in at -$960,000.

  • Going back by year, Non Operating Interest Expenses was $24.68 million in FY2024 (-20.0%), $30.84 million in FY2023 (+35.9%), $22.7 million in FY2022 (+15.4%) and $19.67 million in FY2021 (-26.5%).
  • The five-year range for quarterly Non Operating Interest Expenses is -$13.36 million (Q3 2025) to $9.22 million (Q2 2024).
  • Year-over-year, Non Operating Interest Expenses increased in two of the last six quarters, with an average decline of 3.9%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2025 (growth of 174.7%), and the weakest in Q2 2025 (a decline of 99.8%).
  • Business Quant data shows OMER's Non Operating Interest Expenses at $5.89 million (Q1 2026), $8.73 million (Q4 2025) and -$13.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Omeros 1.37 Bn 1.37 Bn 27.73 Mn 7.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.59 Mn
Mar 31, 2026 5.89 Mn
Dec 31, 2025 8.73 Mn
Sep 30, 2025 -13.36 Mn
Jun 30, 2025 15,000.00
Mar 31, 2025 3.65 Mn
Dec 31, 2024 3.18 Mn
Sep 30, 2024 4.05 Mn
Jun 30, 2024 9.22 Mn
Mar 31, 2024 8.23 Mn
Dec 31, 2023 7.06 Mn
Sep 30, 2023 7.92 Mn
Jun 30, 2023 7.93 Mn
Mar 31, 2023 7.93 Mn
Dec 31, 2022 7.90 Mn
Sep 30, 2022 4.93 Mn
Jun 30, 2022 4.93 Mn
Mar 31, 2022 4.94 Mn
Dec 31, 2021 4.95 Mn
Sep 30, 2021 4.91 Mn
API Access

Omeros Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OMER&period=max&api_key=YOUR_API_KEY